Carboxylated Polystyrene Latex Beads (5.0–5.9 µm) – Catalog #B2025494

Carboxylated polystyrene latex beads (Catalog #B2025494) are supplied as 5 mL of a uniform suspension of polymer spheres, 5.0 to 5.9 micrometers in diameter. Each particle carries carboxyl (–COOH) groups on its surface that are ionized at physiological pH, creating a stable negative charge. This carboxylation enables straightforward chemical coupling of proteins, peptides, antibodies, and other ligands via carbodiimide or other standard chemistries. The beads' micrometer size makes them easy to handle and ideal for immunoassays, diagnostic platforms, and flow cytometry applications where larger particles are preferred over nanoparticles.

Scientific Overview

Polystyrene has been the material of choice for bead-based diagnostics and immunoassays for decades because of its chemical stability, uniform synthesis at defined sizes, straightforward chemical modification, and ease of handling in automated systems. Carboxylation via copolymerization with methacrylic acid or post-synthetic treatment adds ionizable surface groups that are negatively charged at physiological pH. This negative charge stabilizes the suspension against aggregation (through electrostatic repulsion) and provides a chemical handle for ligand attachment via carbodiimide-mediated coupling or other conjugation chemistries.

At 5–6 µm, these beads occupy a sweet spot for many applications: they are large enough to be convenient for pipetting and flow cytometry, yet small enough that their surface-area-to-volume ratio supports efficient protein binding and rapid assay kinetics. This size range is particularly well-suited to immunoassays, where beads serve as a solid phase for antibody or antigen capture, and to bead-based sensors used in point-of-care diagnostics.

Key applications include:

• Solid-phase immunoassays (sandwich ELISA, competitive assays, radioimmunoassays)
• Antibody immobilization for capture-based diagnostics
• Flow cytometry and cell sorting with antibody-coated beads
• Bead-based biosensors and diagnostic platforms
• Affinity purification and biomolecule capture

Usage & Handling Guidance

Store the suspension at 2–8°C in the original container. Invert several times before use to ensure even distribution. For protein coating, dilute the beads into ultrapure water or phosphate-buffered saline and activate with carbodiimide (e.g., 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, or EDAC) and N-hydroxysuccinimide (NHS) to form reactive esters on the carboxyl groups, then incubate with the target protein. Specific coupling protocols depend on the protein's pI, concentration, and desired coating density; optimization may be required for your application.

• Activation: Use EDAC/NHS chemistry to convert carboxyl groups to reactive N-hydroxysuccinimide esters for amine-coupling. Follow published protocols for your target biomolecule.
• Coupling efficiency: Depends on protein concentration, pH, ionic strength, and incubation time. Test coupling with your specific antibody or protein to determine optimal conditions.
• Washing: After coupling, wash beads multiple times with PBS or storage buffer to remove excess reactants and unbound protein.
• Bead concentration: Optimize bead concentration for your assay format (typically 10⁶ to 10⁸ beads/mL depending on the application).

What You Get

• 5 mL of carboxylated polystyrene latex bead suspension
• Uniform 5.0–5.9 µm particles with well-defined negative surface charge
• A convenient starting material for immunoassay development and diagnostic platform design
• For research use only (RUO)

Why Researchers Choose It

• Uniform, well-characterized size distribution ideal for immunoassays
• Straightforward surface chemistry for protein and antibody immobilization
• Convenient micrometer size for handling and flow cytometry
• Proven track record in solid-phase immunoassays and diagnostics
• Stable aqueous suspension ready to use

Frequently Asked Questions (FAQ)

• How do I couple antibodies to the beads?
  Activate the carboxyl groups using EDAC/NHS chemistry to form reactive succinimide esters, then incubate with your antibody of interest. The amine groups (typically at lysine residues and the N-terminus) on your antibody will form amide bonds with the activated carboxyls. Optimize pH, temperature, and incubation time for efficient coupling.
• What is the binding capacity?
  Binding capacity depends on the target protein's size and the desired coating density. Test with your specific antibody to determine optimal protein coverage and binding capacity for your assay.
• Are these beads suitable for automated systems?
  Yes. The uniform size and density allow them to be used in automated microplate readers and liquid handling systems. Consult the system's documentation for bead compatibility.
• Can I use these for flow cytometry?
  Yes. The micrometer size is ideal for flow cytometry. Fluorescent labeling protocols are well-established in the literature, and antibody-coated beads are commonly used as positive controls or in bead-based assays.
• How should I store coated beads?
  Store coated beads at 2–8°C in storage buffer (typically PBS with 0.02% sodium azide as a preservative). Do not freeze unless specifically indicated.
• Can I get a TDS or COA?
  Yes. Request a quote or contact us and we will provide available lot documentation.

References

• Gupta SK, Guesdon JL, Avrameas S, Talwar GP. Sandwich enzyme immunoassay of human chorionic gonadotropin using polystyrene beads as solid support. Ann Inst Pasteur Immunol (1985). 1985;136D(1):47-55.
• Hashida S, Ishikawa S, Nakamoto H, Tanaka S, Kojima M, Ishikawa E. Simple and more sensitive immune complex transfer enzyme immunoassay for antibody IgG to reverse transcriptase of HIV-1 using microplates, modified polystyrene solid phase and fluororeader. J Clin Lab Anal. 1996;10(5):294-301.
• Schoof E, John MR, Arndt B, Gao P, Theuer D, Sieg A, Schmidt-Gayk H. Solid phase competitive luminescence immunoassay for immunoglobulin A in faeces: development and clinical validation. Clin Chim Acta. 1997;261(1):1-17.